NUPLAZID
Active substance: pimavanserin
CAPSULE · PIMAVANSERIN TARTRATE 34 mg/1
United StatesActive
Marketing holder: Acadia Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- PIMAVANSERIN TARTRATE · 34 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2aeb-72f4-b89e-3d0c228a8967,01a12090-2f60-7f14-bdd1-39e00c71c11b,01a12092-28e0-739c-bbc6-a58334069fb9;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 63090-340
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 63090-340 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63090-340 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63090-340 · Verified 2026-10-09 · open in source